久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • ITM, DCB sign agreement for Targeted Radionuclide Therapy biospectrumasia
    September 03, 2019
    The agreement sets out terms concerning the local development, registration and subsequent commercialization by DCB of ITM’s proprietary brand Solucin? for Targeted Radionuclide Therapy (TRT).
  • Medtronic introduces IN.PACT Admiral DCB in Japan biospectrumasia
    August 20, 2018
    IN.PACT Admiral DCB is a clinically proven, primary endovascular therapy that treats femoropopliteal disease, reduces interventions, and preserves future treatment options.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service